123 related articles for article (PubMed ID: 10827420)
1. Evidence is lacking for a synergistic or additive effect of combination extracorporeal photopheresis with interferon alfa for cutaneous T-cell lymphoma.
Zackheim HS
J Am Acad Dermatol; 2000 Jun; 42(6):1087-8. PubMed ID: 10827420
[No Abstract] [Full Text] [Related]
2. Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.
Richardson SK; McGinnis KS; Shapiro M; Lehrer MS; Kim EJ; Vittorio CC; Junkins Hopkins JM; Rook AH
J Cutan Med Surg; 2003; 7(4 Suppl):8-12. PubMed ID: 12958701
[No Abstract] [Full Text] [Related]
3. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis.
Lee CH; Mamelak AJ; Vonderheid EC
Int J Dermatol; 2007 Nov; 46(11):1198-204. PubMed ID: 17988344
[TBL] [Abstract][Full Text] [Related]
4. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
Ferenczi K; Yawalkar N; Jones D; Kupper TS
Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
[TBL] [Abstract][Full Text] [Related]
5. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R
J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006
[TBL] [Abstract][Full Text] [Related]
6. Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome.
Fritz TM; Kleinhans M; Nestle FO; Burg G; Dummer R
Br J Dermatol; 1999 Jun; 140(6):1144-7. PubMed ID: 10354086
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic advances in biological response modifiers in the treatment of cutaneous T-cell lymphoma.
Vittorio CC; Rook AH; French LE; Shapiro M; Lehrer MS; Junkins-Hopkins JM
BioDrugs; 2001; 15(7):431-7. PubMed ID: 11520254
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome.
Booken N; Weiss C; Utikal J; Felcht M; Goerdt S; Klemke CD
J Dtsch Dermatol Ges; 2010 Jun; 8(6):428-38. PubMed ID: 20180887
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma.
Dippel E; Schrag H; Goerdt S; Orfanos CE
Lancet; 1997 Jul; 350(9070):32-3. PubMed ID: 9217723
[No Abstract] [Full Text] [Related]
10. Treatment of cutaneous T cell lymphoma stage II with interferon-alpha-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
Ann N Y Acad Sci; 2001 Sep; 941():210-3. PubMed ID: 11594576
[No Abstract] [Full Text] [Related]
11. Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma.
Knobler R; Jantschitsch C
Transfus Apher Sci; 2003 Feb; 28(1):81-9. PubMed ID: 12620272
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma.
Duvic M; Chiao N; Talpur R
J Cutan Med Surg; 2003; 7(4 Suppl):3-7. PubMed ID: 12958700
[No Abstract] [Full Text] [Related]
14. Therapeutic applications of photopheresis.
Rook AH; Cohen JH; Lessin SR; Vowels BR
Dermatol Clin; 1993 Apr; 11(2):339-47. PubMed ID: 8477547
[TBL] [Abstract][Full Text] [Related]
15. Aggressive squamous cell carcinomas in patients treated with extracorporeal photopheresis for cutaneous T-cell lymphoma.
Nehal KS; Green KB; Lim HW
Arch Dermatol; 1995 Oct; 131(10):1211-2. PubMed ID: 7574848
[No Abstract] [Full Text] [Related]
16. Photopheresis for the treatment of cutaneous T-cell lymphoma.
Lim HW; Edelson RL
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1117-26. PubMed ID: 8522488
[TBL] [Abstract][Full Text] [Related]
17. Metastasizing squamous cell carcinomas in a patient treated with extracorporeal photopheresis for cutaneous T-cell lymphoma.
Hoetzenecker W; Benedix F; Woelbing F; Yazdi A; Breuninger H; Röcken M; Berneburg M
Acta Derm Venereol; 2007; 87(5):445-6. PubMed ID: 17721661
[No Abstract] [Full Text] [Related]
18. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649
[TBL] [Abstract][Full Text] [Related]
19. Survival of patients with cutaneous T cell lymphoma after treatment with extracorporeal photochemotherapy: a retrospective single-center analysis.
Wollina U; Liebold K; Kaatz M; Looks A; Stuhlert A; Lange D
Ann N Y Acad Sci; 2001 Sep; 941():217-9. PubMed ID: 11594578
[No Abstract] [Full Text] [Related]
20. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
